End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.
Identifieur interne : 000359 ( Main/Exploration ); précédent : 000358; suivant : 000360End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.
Auteurs : Rachel L. Beanland [Suisse] ; Cadi M. Irvine [Suisse] ; Kimberly Green [Ghana]Source :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1537-6591 ] ; 2015.
Descripteurs français
- KwdFr :
- Agents antiVIH (usage thérapeutique), Besoins et demandes de services de santé, Enquêtes et questionnaires, Guides de bonnes pratiques cliniques comme sujet, Humains, Infections à VIH (), Infections à VIH (transmission), Organisation mondiale de la santé, Prophylaxie après exposition, Préférence du patient.
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anti-HIV Agents.
- prevention & control : HIV Infections.
- transmission : HIV Infections.
- Health Services Needs and Demand, Humans, Patient Preference, Post-Exposure Prophylaxis, Practice Guidelines as Topic, Surveys and Questionnaires, World Health Organization.
Abstract
The 2014 World Health Organization guidelines for human immunodeficiency virus postexposure prophylaxis (PEP) are the first to combine recommendations for all populations and exposures. To inform the development of these guidelines, we gathered views of end users on key aspects of PEP provision. A mixed-methods approach was used to gather views from the populations for whom the guideline will be of relevance. Data gathered from an online survey, focus group discussions, and previously collected data from in-depth interviews with key populations were used to inform the development of recommendations, in particular where there is a paucity of evidence to assess the benefits and harms of an intervention. This was a successful method to gather end users' views and preferences; however, limitations exist in the generalizability and reliability of the evidence. Future guideline development processes should consider methods to include the views of end users to guide the decision-making process.
DOI: 10.1093/cid/civ070
PubMed: 25972503
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000628
- to stream PubMed, to step Curation: 000628
- to stream PubMed, to step Checkpoint: 000628
- to stream Ncbi, to step Merge: 000823
- to stream Ncbi, to step Curation: 000823
- to stream Ncbi, to step Checkpoint: 000823
- to stream Main, to step Merge: 000359
- to stream Main, to step Curation: 000359
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.</title><author><name sortKey="Beanland, Rachel L" sort="Beanland, Rachel L" uniqKey="Beanland R" first="Rachel L" last="Beanland">Rachel L. Beanland</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Irvine, Cadi M" sort="Irvine, Cadi M" uniqKey="Irvine C" first="Cadi M" last="Irvine">Cadi M. Irvine</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Green, Kimberly" sort="Green, Kimberly" uniqKey="Green K" first="Kimberly" last="Green">Kimberly Green</name><affiliation wicri:level="3"><nlm:affiliation>FHI 360, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>FHI 360, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25972503</idno><idno type="pmid">25972503</idno><idno type="doi">10.1093/cid/civ070</idno><idno type="wicri:Area/PubMed/Corpus">000628</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000628</idno><idno type="wicri:Area/PubMed/Curation">000628</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000628</idno><idno type="wicri:Area/PubMed/Checkpoint">000628</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000628</idno><idno type="wicri:Area/Ncbi/Merge">000823</idno><idno type="wicri:Area/Ncbi/Curation">000823</idno><idno type="wicri:Area/Ncbi/Checkpoint">000823</idno><idno type="wicri:Area/Main/Merge">000359</idno><idno type="wicri:Area/Main/Curation">000359</idno><idno type="wicri:Area/Main/Exploration">000359</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.</title><author><name sortKey="Beanland, Rachel L" sort="Beanland, Rachel L" uniqKey="Beanland R" first="Rachel L" last="Beanland">Rachel L. Beanland</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Irvine, Cadi M" sort="Irvine, Cadi M" uniqKey="Irvine C" first="Cadi M" last="Irvine">Cadi M. Irvine</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Green, Kimberly" sort="Green, Kimberly" uniqKey="Green K" first="Kimberly" last="Green">Kimberly Green</name><affiliation wicri:level="3"><nlm:affiliation>FHI 360, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>FHI 360, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName></affiliation></author></analytic><series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title><idno type="eISSN">1537-6591</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-HIV Agents (therapeutic use)</term><term>HIV Infections (prevention & control)</term><term>HIV Infections (transmission)</term><term>Health Services Needs and Demand</term><term>Humans</term><term>Patient Preference</term><term>Post-Exposure Prophylaxis</term><term>Practice Guidelines as Topic</term><term>Surveys and Questionnaires</term><term>World Health Organization</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents antiVIH (usage thérapeutique)</term><term>Besoins et demandes de services de santé</term><term>Enquêtes et questionnaires</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Infections à VIH ()</term><term>Infections à VIH (transmission)</term><term>Organisation mondiale de la santé</term><term>Prophylaxie après exposition</term><term>Préférence du patient</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Services Needs and Demand</term><term>Humans</term><term>Patient Preference</term><term>Post-Exposure Prophylaxis</term><term>Practice Guidelines as Topic</term><term>Surveys and Questionnaires</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Besoins et demandes de services de santé</term><term>Enquêtes et questionnaires</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Infections à VIH</term><term>Organisation mondiale de la santé</term><term>Prophylaxie après exposition</term><term>Préférence du patient</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 2014 World Health Organization guidelines for human immunodeficiency virus postexposure prophylaxis (PEP) are the first to combine recommendations for all populations and exposures. To inform the development of these guidelines, we gathered views of end users on key aspects of PEP provision. A mixed-methods approach was used to gather views from the populations for whom the guideline will be of relevance. Data gathered from an online survey, focus group discussions, and previously collected data from in-depth interviews with key populations were used to inform the development of recommendations, in particular where there is a paucity of evidence to assess the benefits and harms of an intervention. This was a successful method to gather end users' views and preferences; however, limitations exist in the generalizability and reliability of the evidence. Future guideline development processes should consider methods to include the views of end users to guide the decision-making process.</div></front></TEI><affiliations><list><country><li>Ghana</li><li>Suisse</li></country><region><li>Région du Grand Accra</li></region><settlement><li>Accra</li></settlement></list><tree><country name="Suisse"><noRegion><name sortKey="Beanland, Rachel L" sort="Beanland, Rachel L" uniqKey="Beanland R" first="Rachel L" last="Beanland">Rachel L. Beanland</name></noRegion><name sortKey="Irvine, Cadi M" sort="Irvine, Cadi M" uniqKey="Irvine C" first="Cadi M" last="Irvine">Cadi M. Irvine</name></country><country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Green, Kimberly" sort="Green, Kimberly" uniqKey="Green K" first="Kimberly" last="Green">Kimberly Green</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000359 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000359 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25972503
|texte= End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25972503" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |